Filter Results
:
(26)
Show Results For
-
All HBS Web
(115,785)
- Faculty Publications (26)
Show Results For
-
All HBS Web
(115,785)
- Faculty Publications (26)
Page 1 of
26
Results
→
- April 2024
- Case
Managing AI Risks in Consumer Banking
By: Suraj Srinivasan, Satish Tadikonda, Paul Dongha, Manoj Saxena and Radhika Kak
In early 2024, Ruth Jones, head of digital banking at Signa Bank, a (fictitious) European consumer bank, was thinking about how to best incorporate GenAI capabilities to improve efficiencies and create new ways to improve the customer experience. Where were the biggest...
View Details
Srinivasan, Suraj, Satish Tadikonda, Paul Dongha, Manoj Saxena, and Radhika Kak. "Managing AI Risks in Consumer Banking." Harvard Business School Case 124-093, April 2024.
- March 2024
- Supplement
Miracle Therapeutics (B)
By: Satish Tadikonda, William Marks and Wendi Yajnik
Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024.
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely...
View Details
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- October 2023 (Revised April 2024)
- Case
Veeva Systems: The Next Frontier
By: Satish Tadikonda and William Marks
Born out of a desire to bring technological advances in enterprise software into the healthcare vertical, Peter Gassner and Matt Wallach founded Veeva to bring life sciences companies into the digital age for data management in both the commercial and R&D sectors. Over...
View Details
Tadikonda, Satish, and William Marks. "Veeva Systems: The Next Frontier." Harvard Business School Case 824-074, October 2023. (Revised April 2024.)
- October 2023 (Revised April 2024)
- Case
TetraScience: Unlocking the Power of Scientific Data
By: Satish Tadikonda and William Marks
Tadikonda, Satish, and William Marks. "TetraScience: Unlocking the Power of Scientific Data." Harvard Business School Case 824-072, October 2023. (Revised April 2024.)
- October 2023 (Revised October 2023)
- Case
Thermo Fisher Scientific: Foray Into Contract Research
By: Satish Tadikonda, William Marks and Kevin Emancipator
- October 2023 (Revised October 2023)
- Case
Alnylam (A): A Loud Silence
By: Satish Tadikonda, William Marks and Shardule Shah
- October 2023 (Revised April 2024)
- Supplement
Alnylam (B): A Loud Silence
By: Satish Tadikonda, William Marks and Shardule Shah
- October 2023
- Case
Catalent: Catalyzing the Next Era of Growth
By: Satish Tadikonda, William Marks and Kevin Emancipator
- October 2023
- Case
Revvity: A Symbol of Change
By: Satish Tadikonda and William Marks
After selling the PerkinElmer name and several ancillary business units, Prahlad Singh (CEO) and his team at the newly christened Revvity faced a challenge on how best to capitalize on the opportunities ahead for the business and emerge as winners within the Life...
View Details
Tadikonda, Satish, and William Marks. "Revvity: A Symbol of Change." Harvard Business School Case 824-071, October 2023.
- September 2023
- Case
THREAD Research: Decentralized Clinical Trials and Beyond
By: Satish Tadikonda, Amanda McEwen and William Marks
- September 2023 (Revised April 2024)
- Case
Atomwise: Strategic Opportunities in AI for Pharma
By: Satish Tadikonda
Abraham Heifets and his co-founder, Izhar Wallach, had founded Atomwise to develop i) an AI engine to transform drug discovery by creating better medicines faster, and ii) a machine learning-based discovery engine that combined the power of convolutional neural...
View Details
Tadikonda, Satish. "Atomwise: Strategic Opportunities in AI for Pharma." Harvard Business School Case 824-043, September 2023. (Revised April 2024.)
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
- August 2023 (Revised September 2023)
- Case
Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
- August 2023 (Revised January 2024)
- Case
Jake Becraft and Strand Therapeutics: The Making of an Entrepreneur
By: Satish Tadikonda, William Marks and Ananya Zutshi
- August 2023 (Revised January 2024)
- Case
Three Vignettes of Early Careers in the Life Sciences
By: Satish Tadikonda, Jacqueline Grant and William Marks
- August 2023
- Background Note
A Note on the Differences Between Therapeutics, Medical Devices, and Diagnostics
By: Satish Tadikonda, Ananya Zutshi, Hunter Goble and William Marks
Tadikonda, Satish, Ananya Zutshi, Hunter Goble, and William Marks. "A Note on the Differences Between Therapeutics, Medical Devices, and Diagnostics." Harvard Business School Background Note 824-045, August 2023.
- August 2023
- Teaching Note
Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
Teaching Note for HBS Case No. 824-021.
View Details